Whitehawk Therapeutics (WHWK) Gains from Sales and Divestitures (2016 - 2026)
Whitehawk Therapeutics (WHWK) reported Gains from Sales and Divestitures of $51000.0 for Q1 2026, down 19.05% year-over-year from $63000.0 in Q1 2025, and down 86.86% quarter-over-quarter from $388000.0 in Q4 2025.
Whitehawk Therapeutics (WHWK) Gains from Sales and Divestitures (2016 - 2026) Analysis & Trends
Whitehawk Therapeutics (WHWK) has 5 years of Gains from Sales and Divestitures data on file, last reported at $51000.0 in Q1 2026.
- Gains from Sales and Divestitures for Q1 2026 came in at $51000.0, down 19.05% year-over-year; the trailing twelve-month figure through Mar 2026 was $51000.0 (down 19.05% YoY), and the FY2025 annual result was $388000.0, changed N/A from the prior year.
- Gains from Sales and Divestitures fell to $51000.0 in Q1 2026 per WHWK's latest filing, from $388000.0 in the prior quarter.
- Over five years, Gains from Sales and Divestitures peaked at $388000.0 in Q4 2025 and troughed at $51000.0 in Q1 2026.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - |
| 10 | Whitehawk Therapeutics | 310.18 Mn | 187.14 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 51,000.00 |
| Mar 31, 2026 | 51,000.00 |
| Dec 31, 2025 | 388,000.00 |
| Dec 31, 2025 | 388,000.00 |
| Sep 30, 2025 | 387,925.00 |
| Sep 30, 2025 | 387,925.00 |
| Jun 30, 2025 | 325,000.00 |
| Jun 30, 2025 | 325,000.00 |
| Mar 31, 2025 | 63,000.00 |
| Mar 31, 2025 | 63,000.00 |
| Dec 31, 2018 | 149,243.00 |
| Dec 31, 2018 | 149,243.00 |
| Sep 30, 2018 | 142,205.00 |
| Sep 30, 2018 | 142,205.00 |
| Jun 30, 2018 | 97,020.00 |
| Jun 30, 2018 | 97,020.00 |
| Mar 31, 2018 | 70,605.00 |
| Mar 31, 2018 | 70,605.00 |
| Dec 31, 2017 | 144,274.00 |
| Dec 31, 2017 | 144,274.00 |